VIVOS THERAPEUTICS INC (VVOS:NASDAQ)

$0.7222 0.0222 (3.1714%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 68

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed VIVOS THERAPEUTICS INC (VVOS:NASDAQ) News Sources

New to The Street Broadcasts on Bloomberg Television at 6:30 PM EST Featuring IGC Pharma (IGC), Vivos Therapeutics (VVOS), Acurx Pharmaceuticals (ACXP), and Equinox Gold (EQX)

11-04-2026

yahoo.com

New to The Street to Broadcast on Fox Business on Monday, April 13, Featuring Virtuix Holdings (NASDAQ:VTIX), Medicus Pharma (NASDAQ:MDCX), YY Group Holdings (NASDAQ:YYGH), Vivos Therapeutics (NASDAQ:VVOS), and Stardust Power (NASDAQ:SDST)

11-04-2026

yahoo.com

Vivos Therapeutics, Inc. Q4 2025 Earnings Call Summary

15-04-2026

moby.co

Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results and Conference Call

15-04-2026

yahoo.com

Vivos Therapeutics Reports Full Year 2025 Financial Results

15-04-2026

yahoo.com

Vivos Therapeutics Inc (VVOS) Q4 2025 Earnings Call Highlights: Revenue Growth Amid Strategic ...

16-04-2026

yahoo.com

New to The Street to Broadcast Tonight on Bloomberg at 6:30 PM EST - Show #744 Featuring Virtuix Holdings (NASDAQ:VTIX), Neonc Technologies Holdings (NASDAQ:NTHI), Medicus Pharma (NASDAQ:MDCX), YY Group Holding (NASDAQ:YYGH), and Vivos Therapeutics (NASDAQ:VVOS)

18-04-2026

yahoo.com

Plus Therapeutics (PSTV) Reports Q1 Loss, Tops Revenue Estimates

15-05-2026

yahoo.com

Vivos Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Update

20-05-2026

yahoo.com

Vivos Therapeutics Inc (VVOS) Q1 2026 Earnings Call Highlights: Revenue Surges Amid Strategic Shifts

29-05-2026

yahoo.com

VIVOS THERAPEUTICS INC (VVOS:NASDAQ) Sentiment Trend

0 25 50 75 100 65 66 75 69 73 92 62 3 84 92 11-04-2026 15-04-2026 16-04-2026 18-04-2026 15-05-2026 20-05-2026 29-05-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

VIVOS THERAPEUTICS INC (VVOS:NASDAQ) FAQs

toggle

What is the current price of VIVOS THERAPEUTICS INC (VVOS:NASDAQ)?

The current price of VIVOS THERAPEUTICS INC (VVOS:NASDAQ) is $0.7222.


toggle

VIVOS THERAPEUTICS INC (VVOS:NASDAQ) absolute price change since previous trading day?

The absolute price change of VIVOS THERAPEUTICS INC (VVOS:NASDAQ) since the previous trading day is $0.0222.


toggle

VIVOS THERAPEUTICS INC (VVOS:NASDAQ) percentage price change since previous trading day?

The percentage price change of VIVOS THERAPEUTICS INC (VVOS:NASDAQ) since the previous trading day is 3.1714%.


toggle

What is the most recent average sentiment score for VIVOS THERAPEUTICS INC (VVOS:NASDAQ)?

The most recent average sentiment score for VIVOS THERAPEUTICS INC (VVOS:NASDAQ) is 68 out of 100.


toggle

What is the most recent average sentiment for VIVOS THERAPEUTICS INC (VVOS:NASDAQ)?

The most recent sentiment for VIVOS THERAPEUTICS INC (VVOS:NASDAQ) is .


SEC-8K** Filing Available For VIVOS THERAPEUTICS INC (VVOS:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.